Change to UK Rare Disease Approval Process

The Times reports that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is revising it’s approach to how it approves new medicines that treat rare diseases. How? Principally by allowing for single arm trials with real-world ‘digital twin’ controls as well as expediting the approval process. The new plan, which is being launched on…

Read More

3 Misconceptions Hospital Leaders Have About AI

During Reuters’ MedTech conference, medical device leaders shared three common misconceptions they believe hospital leaders often have about AI. They stressed that AI in healthcare is meant to augment — not replace — clinicians. The post 3 Misconceptions Hospital Leaders Have About AI appeared first on MedCity News.

Read More